WebThe Investor Relations department of Evotec SE acts as an interface between the Company and the capital markets. Our extensive investor relations work focuses on an active, regular, comprehensive and transparent dialogue with our stakeholders, including shareholders, existing and potential investors, analysts, banks and the financial press. ... WebJul 17, 2024 · Galapagos Investor Relations [email protected] ***** This announcement contains inside information of Galapagos Holding S.A. for the purposes of Article 7 under Regulation (EU) 596/2014. Galapagos Holding S.A. is a public limited liability company (Société Anonyme) incorporated under the laws of the Grand …
DGAP-News: Galapagos S.A.: Notice Markets Insider
WebJan 7, 2014 · Investor Relations at Galapagos (Belgium). Investment banking (KBC Securities, 4y) - Biotech and pharma company/product valuations, public/private investor relations worldwide. Follow-up of stock listed European biotech/pharma. Biotech startup (iTeos, 4y) - Department head: Management of internal R&D activities in Immune … WebMangrove LuxCo III S.à r.l. was incorporated 2024 in Luxembourg and indirectly holds the two operational segments Kelvion and ENEXIO. Kelvion and ENEXIO are responsible for their respective markets, products, … bandar icecream khata hai
JYSELECA® (FILGOTINIB) LICENSED FOR THE TREATMENT OF ADULT
WebAug 2, 2024 · [email protected] ***** This announcement contains inside information of Galapagos S.A. for the purposes of Article 7 under Regulation (EU) 596/2014. Galapagos S.A. is a public ... WebJul 17, 2024 · EQS-News: Galapagos S.A. / Key word(s): Miscellaneous 17.07.2024 / 11:00 The issuer is solely responsible for the content of this announcement. * * *NOTICEGalapagos S.A. Effective Place of Management: 20 Davis Way Newgate Lane Fareham Hampshire PO14 1AR United KingdomSenior Secured Floating Rate Notes … WebNov 23, 2024 · Contacts Galapagos Investors: Elizabeth Goodwin VP Investor Relations +1 781 460 1784. Sofie Van Gijsel Senior Director Investor Relations +32 485 19 14 15 [email protected] Media: artikel kkn undip